Abstract: Arsenic compounds of general formula (I), their preparation methods, the pharmaceutical compositions containing the compounds, and their uses in the manufacture of medicaments for treating cancer, particularly leukemia, are disclosed.
Type:
Grant
Filed:
April 16, 2010
Date of Patent:
December 8, 2015
Assignee:
Changzhou Hi-Tech District Multiple Dimension Industry Technology Institute Co., Ltd.
Abstract: This invention relates to a pharmaceutical composition for preventing and curing myocardium ischemia and reducing area of myocardial infarction, its pharmaceutical preparation and applications. The composition includes (a) levocarnitine or its derivatives, and (b) trimetazidine or its medicative salts. The quantity of levocarnitine or its derivatives, and trimetazidine or its medicative salts in the composition is effective amount for treating myocardial ischemia and reducing the area of myocardial infarction.
Type:
Grant
Filed:
May 28, 2008
Date of Patent:
August 20, 2013
Assignee:
Changzhou Hi-Tech District Multiple Dimension Industry Technology Institute Co., Ltd.
Inventors:
Shuhua Gu, Changlin Mei, Dingfeng Su, Juan Du, Rong Fan
Abstract: Arsenic compounds of general formula (I), their preparation methods, the pharmaceutical compositions containing the compounds, and their uses in the manufacture of medicaments for treating cancer, particularly leukemia, are disclosed.
Type:
Application
Filed:
April 16, 2010
Publication date:
February 16, 2012
Applicant:
Changzhou Hi-Tech District Multiple Dimension Industry Technology Institute Co., Ltd.